Sign In
Buy HRTX
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
Heron Therapeutics Inc (NASDAQ:HRTX) Expected to Announce Quarterly Sales of $20.89 Million
10:42am, Tuesday, 10'th Mar 2020
Analysts expect that Heron Therapeutics Inc (NASDAQ:HRTX) will announce sales of $20.89 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided esti
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
Mackay Shields LLC Has $1.46 Million Stock Holdings in Heron Therapeutics Inc (NASDAQ:HRTX)
09:02am, Monday, 09'th Mar 2020
Mackay Shields LLC trimmed its position in Heron Therapeutics Inc (NASDAQ:HRTX) by 19.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Excha
FY2020 Earnings Estimate for Heron Therapeutics Inc Issued By Cantor Fitzgerald (NASDAQ:HRTX)
06:42am, Monday, 09'th Mar 2020
Heron Therapeutics Inc (NASDAQ:HRTX) – Stock analysts at Cantor Fitzgerald reduced their FY2020 earnings per share (EPS) estimates for shares of Heron Therapeutics in a research report issued on Thu
Charles Schwab Investment Management Inc. Raises Holdings in Heron Therapeutics Inc (NASDAQ:HRTX)
08:16am, Sunday, 08'th Mar 2020
Charles Schwab Investment Management Inc. lifted its stake in Heron Therapeutics Inc (NASDAQ:HRTX) by 15.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exc
Heron Therapeutics (NASDAQ:HRTX) Trading Down 7.1%
07:26am, Friday, 06'th Mar 2020
Shares of Heron Therapeutics Inc (NASDAQ:HRTX) traded down 7.1% during mid-day trading on Thursday . The stock traded as low as $17.06 and last traded at $17.32, 1,154,089 shares were traded during tr
Heron Therapeutics Inc Forecasted to Earn Q1 2020 Earnings of ($0.59) Per Share (NASDAQ:HRTX)
04:48pm, Thursday, 05'th Mar 2020
Heron Therapeutics Inc (NASDAQ:HRTX) – Investment analysts at Jefferies Financial Group issued their Q1 2020 earnings estimates for shares of Heron Therapeutics in a report issued on Monday, March 2
Despite Lacking Profits Heron Therapeutics (NASDAQ:HRTX) Seems To Be On Top Of Its Debt
12:53pm, Wednesday, 04'th Mar 2020
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Heron Therapeutics (NASDAQ:HRTX) PT Lowered to $44.00
09:16am, Wednesday, 04'th Mar 2020
Heron Therapeutics (NASDAQ:HRTX) had its price objective decreased by analysts at Needham & Company LLC from $48.00 to $44.00 in a research report issued to clients and investors on Monday, BenzingaRa
Analysts Conflicted on These Healthcare Names: EyePoint Pharmaceuticals (EYPT), uniQure (QURE) and Heron Therapeutics (HRTX)
12:10pm, Tuesday, 03'rd Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on EyePoint Pharmaceuticals (EYPT), uniQure (QURE) and Heron
Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on EyePoint Pharmaceuticals (
EYPT
–
Research Report
), uniQure (
QURE
–
Research Report
) and Heron T
Heron Therapeutics (NASDAQ:HRTX) Rating Reiterated by Stifel Nicolaus
08:52am, Tuesday, 03'rd Mar 2020
Heron Therapeutics (NASDAQ:HRTX)‘s stock had its “buy” rating restated by stock analysts at Stifel Nicolaus in a note issued to investors on Monday, TipRanks reports. They currently have a $29.0
Needham Maintains Buy on Heron Therapeutics, Lowers Price Target to $44
05:36pm, Monday, 02'nd Mar 2020Heron Therapeutics (HRTX) Received its Third Buy in a Row
03:58pm, Monday, 02'nd Mar 2020
After Cowen & Co. and Cantor Fitzgerald gave Heron Therapeutics (NASDAQ: HRTX) a Buy rating last month, the company received another Buy, this time
Heron Therapeutics (HRTX) Received its Third Buy in a Row
03:57pm, Monday, 02'nd Mar 2020
After Cowen & Co. and Cantor Fitzgerald gave Heron Therapeutics (NASDAQ: HRTX) a Buy rating last month, the company received
